This is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e., on February 05, 2026, had inter-alia considered and approved the following: 1. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
National Peroxide Limited's Board, at its meeting on February 05, 2026, approved the unaudited financial results for Q3 and nine months ended December 31, 2025. Revenue from operations for Q3 FY26 stood at ₹6,215.78 lakhs, down from ₹6,828.63 lakhs in Q3 FY25. For nine months, revenue declined to ₹20,402.85 lakhs from ₹21,316.96 lakhs. However, profit after tax improved sharply to ₹63.44 lakhs in Q3 FY26 versus ₹38.59 lakhs in the year-ago quarter, while the nine-month period turned around from a loss of ₹151.90 lakhs to a profit of ₹183.23 lakhs. The Board also approved the appointment of Mr. Akshay Satasiya as Company Secretary & Compliance Officer effective March 09, 2026. Statutory auditors Kalyaniwalla & Mistry LLP issued a clean (unmodified) limited review report.
Mixed signals for shareholders: top-line is weakening year-on-year, but profitability has improved meaningfully, helped by lower input costs and an exceptional item of ₹58.15 lakhs related to the new Social Security Code. The new Company Secretary appointment is a routine governance update and unlikely to move the stock.